Next Article in Journal
The State of Play with iPSCs and Spinal Cord Injury Models
Next Article in Special Issue
Tapping Stem Cells to Target AMD: Challenges and Prospects
Previous Article in Journal
Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
Previous Article in Special Issue
Role of Factor H and Related Proteins in Regulating Complement Activation in the Macula, and Relevance to Age-Related Macular Degeneration
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

NLRP3 Inflammasome and Pathobiology in AMD

1
Neurovascular Genetics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Lincoln Place Gate, Dublin 2, Ireland
2
Department of Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin 2, Ireland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2015, 4(1), 172-192; https://doi.org/10.3390/jcm4010172
Submission received: 1 October 2014 / Accepted: 19 December 2014 / Published: 14 January 2015
(This article belongs to the Special Issue Age-Related Macular Disease)

Abstract

Age-related macular degeneration (AMD) is the leading cause of central vision loss and blindness in the elderly. It is characterized by a progressive loss of photoreceptors in the macula due to damage to the retinal pigment epithelium (RPE). Clinically, it is manifested by drusen deposition between the RPE and underlying choroid and accumulation of lipofuscin in the RPE. End-stage disease is characterized by geographic atrophy (dry AMD) or choroidal neovascularization (wet AMD). The NLRP3 inflammasome has recently been implicated in the disease pathology. Here we review the current knowledge on the involvement of this multiprotein complex and its effector cytokines interleukin-1β (IL-1β) and IL-18 in AMD progression. We also describe cell death mechanisms that have been proposed to underlie RPE degeneration in AMD and discuss the role of autophagy in the regulation of disease progression.
Keywords: age-related macular degeneration; NLRP3 inflammasome; IL-18; geographic atrophy; choroidal neovascularization; retinal pigment epithelium; pyroptosis; autophagy age-related macular degeneration; NLRP3 inflammasome; IL-18; geographic atrophy; choroidal neovascularization; retinal pigment epithelium; pyroptosis; autophagy
Graphical Abstract

Share and Cite

MDPI and ACS Style

Celkova, L.; Doyle, S.L.; Campbell, M. NLRP3 Inflammasome and Pathobiology in AMD. J. Clin. Med. 2015, 4, 172-192. https://doi.org/10.3390/jcm4010172

AMA Style

Celkova L, Doyle SL, Campbell M. NLRP3 Inflammasome and Pathobiology in AMD. Journal of Clinical Medicine. 2015; 4(1):172-192. https://doi.org/10.3390/jcm4010172

Chicago/Turabian Style

Celkova, Lucia, Sarah L. Doyle, and Matthew Campbell. 2015. "NLRP3 Inflammasome and Pathobiology in AMD" Journal of Clinical Medicine 4, no. 1: 172-192. https://doi.org/10.3390/jcm4010172

APA Style

Celkova, L., Doyle, S. L., & Campbell, M. (2015). NLRP3 Inflammasome and Pathobiology in AMD. Journal of Clinical Medicine, 4(1), 172-192. https://doi.org/10.3390/jcm4010172

Article Metrics

Back to TopTop